🌎 Pfizer Initiated, GSK Downgraded, Moderna Initiated and more...

Ratings changes for Intuitive Machines, AST SpaceMobile, Applied Materials, Moderna, Enphase Energy, bluebird bio, Cabaletta Bio and more...Text "MarketBeat" to  68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports.  Learn More. Unsubscribe. View My Portfolio November 15th, 2024     JD Vance's Shocking Warning: Your Money's Next. (ad) Kamala's Last-Ditch Move: Digital Dollar Control BEFORE Trump Takes Office!   Go here to see why moving your money might be your only way out. Today's Top Stories Top-Performing Non-Leveraged ETFs This Year By Nathan Reiff  |  November 15, 2024 08:01 AM TRUMP WON: Buy gold NOW?  (Ad) By GoldCo Precious Metals U.S. protectionism could undermine modest growth forecast for eurozone, says EU Commission By The Associated Press  |  November 15, 2024 06:50 AM Rivian's Wild Ride: Is the Dip a Buying Opportunity? By Jeffrey Neal Johnson  |  November 15, 2024 07:30 AM URGENT: This Altcoin Opportunity Won't Wait – Act Now  (Ad) By Crypto Swap Profits UK Treasury chief says she's not satisfied by paltry third-quarter economic growth By The Associated Press  |  November 15, 2024 01:38 AM Freshworks Stock Soars 50% – Is This the Perfect Entry Point? By Sam Quirke  |  November 15, 2024 06:47 AM Quick Links Analyst Ratings My MarketBeat Mobile App Account Settings MarketBeat All Access Stock Lists Screener Calculators Premium Reports Morals and money… dollars and democracy (ad) If you missed it, my emergency election broadcast is now available - but will be removed soon   Click here to watch it now. Your Watchlist Your Watchlist You have not added any stocks to your watchlist. Click here to add stocks to your watchlist Analysts' Upgrades Autolus Therapeutics (NASDAQ:AUTL) was upgraded by analysts at Redburn Atlantic from a "neutral" rating to a "buy" rating. They now have a $13.00 price target on the stock. This represents a 315.3% upside from the current price of $3.13. Bloom Energy (NYSE:BE) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $20.00 price target on the stock, up previously from $10.00. This represents a 3.1% upside from the current price of $19.40. BrightView (NYSE:BV) was upgraded by analysts at William Blair from a "market perform" rating to an "outperform" rating.The current price is $15.68. Comerica (NYSE:CMA) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $73.00 price target on the stock, up previously from $51.00. This represents a 5.2% upside from the current price of $69.41. The Descartes Systems Group (NASDAQ:DSGX) (TSE:DSG) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $125.00 price target on the stock, up previously from $88.00. This represents a 12.4% upside from the current price of $111.17. Hanmi Financial (NASDAQ:HAFC) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating.The current price is $25.32. InterContinental Hotels Group (NYSE:IHG) was upgraded by analysts at Barclays PLC from an "equal weight" rating to an "overweight" rating.The current price is $121.35. Independence Realty Trust (NYSE:IRT) was upgraded by analysts at BMO Capital Markets from an "underperform" rating to a "market perform" rating. They now have a $21.00 price target on the stock, up previously from $19.00. Kulicke and Soffa Industries (NASDAQ:KLIC) was upgraded by analysts at Needham & Company LLC from a "hold" rating to a "buy" rating. They now have a $55.00 price target on the stock. This represents a 17.8% upside from the current price of $46.69. Morgan Stanley (NYSE:MS) was upgraded by analysts at Wells Fargo & Company from an "underweight" rating to an "equal weight" rating. They now have a $142.00 price target on the stock, up previously from $107.00. This represents a 6.6% upside from the current price of $133.18. Sally Beauty (NYSE:SBH) was upgraded by analysts at Raymond James from an "underperform" rating to a "market perform" rating.The current price is $13.35. Twilio (NYSE:TWLO) was upgraded by analysts at Monness Crespi & Hardt from a "neutral" rating to a "buy" rating. They now have a $135.00 price target on the stock. This represents a 39.9% upside from the current price of $96.52. UGI (NYSE:UGI) was upgraded by analysts at Mizuho from a "neutral" rating to an "outperform" rating. They now have a $30.00 price target on the stock, up previously from $27.00. This represents a 24.0% upside from the current price of $24.19. View More Upgrades Bill Gates's Next Big AI Bet: Stargate (ad) In February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of my favorite stocks. Shares have jumped by more than 20,000% since then.   I believe we are about to do it again with this new AI project called Stargate Analysts' Downgrades Akoya Biosciences (NASDAQ:AKYA) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $5.00 price target on the stock, down previously from $7.00. This represents a 98.4% upside from the current price of $2.52. Digital Turbine (NASDAQ:APPS) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $1.00 price target on the stock, down previously from $3.50. This represents a 27.5% downside from the current price of $1.38. Alexandria Real Estate Equities (NYSE:ARE) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating. They now have a $112.00 price target on the stock, down previously from $135.00. This represents a 6.6% upside from the current price of $105.10. bluebird bio (NASDAQ:BLUE) was downgraded by analysts at Bank of America Co. from a "buy" rating to a "neutral" rating. They now have a $0.50 price target on the stock, down previously from $3.00. This represents a 55.7% upside from the current price of $0.32. bluebird bio (NASDAQ:BLUE) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.The current price is $0.32. Bionano Genomics (NASDAQ:BNGO) was downgraded by analysts at LADENBURG THALM/SH SH from a "buy" rating to a "neutral" rating.The current price is $0.24. Compass Therapeutics (NASDAQ:CMPX) was downgraded by analysts at Leerink Partners from an "outperform" rating to a "market perform" rating. They now have a $4.00 price target on the stock, down previously from $5.00. This represents a 178.7% upside from the current price of $1.44. DiamondRock Hospitality (NYSE:DRH) was downgraded by analysts at Evercore ISI from an "outperform" rating to an "inline" rating. They now have a $10.50 price target on the stock. This represents a 18.0% upside from the current price of $8.90. GSK (NYSE:GSK) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.The current price is $33.22. Landstar System (NASDAQ:LSTR) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $182.29. NICE (NASDAQ:NICE) was downgraded by analysts at Oppenheimer Holdings Inc. from an "outperform" rating to a "market perform" rating.The current price is $175.94. Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB) was downgraded by analysts at Bank of America Co. from a "buy" rating to an "underperform" rating. They now have a $71.50 price target on the stock. This represents a 12.2% upside from the current price of $63.74. Omega Therapeutics (NASDAQ:OMGA) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $0.79. Royal Bank of Canada (NYSE:RY) (TSE:RY) was downgraded by analysts at TD Securities from a "buy" rating to a "hold" rating.The current price is $120.78. Sachem Capital (NYSEAMERICAN:SACH) was downgraded by analysts at Alliance Global Partners from a "buy" rating to a "neutral" rating.The current price is $1.81. Sow Good (NASDAQ:SOWG) was downgraded by analysts at Roth Mkm from a "buy" rating to a "neutral" rating. They now have a $4.00 price target on the stock, down previously from $17.00. This represents a 4.7% upside from the current price of $3.82. Sow Good (NASDAQ:SOWG) was downgraded by analysts at Craig Hallum from a "buy" rating to a "hold" rating. They now have a $4.50 price target on the stock. This represents a 17.8% upside from the current price of $3.82. Stock Yards Bancorp (NASDAQ:SYBT) was downgraded by analysts at Stephens from an "overweight" rating to an "equal weight" rating. They now have a $76.00 price target on the stock, up previously from $70.00. This represents a 3.8% upside from the current price of $73.21. TreeHouse Foods (NYSE:THS) was downgraded by analysts at Consumer Edge from an "overweight" rating to an "equal weight" rating.The current price is $32.36. Turnstone Biologics (NASDAQ:TSBX) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating.The current price is $0.48. View More Downgrades 5 Stocks Set To Soar From Trump (ad) This Catalyst Hits Once Every 4 Years.. Every four years, on the day of the election, a catalyst is triggered. Over the last 20 years, this catalyst has caused 1,500 stocks to rise an average of 3,700%... within 90 days. And now, Tim Bohen is blowing the whole story wide open on Wednesday, November 20th at 8PM.   Click here for details on your FREE RSVP. Analysts' New Coverage AbbVie (NYSE:ABBV) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $205.00 price target on the stock. This represents a 23.8% upside from the current price of $165.65. Amgen (NASDAQ:AMGN) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $279.95. Biogen (NASDAQ:BIIB) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $160.37. BioMarin Pharmaceutical (NASDAQ:BMRN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $95.00 price target on the stock. This represents a 49.1% upside from the current price of $63.72. Bristol-Myers Squibb (NYSE:BMY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $56.53. CDW (NASDAQ:CDW) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $230.00 price target on the stock. This represents a 29.6% upside from the current price of $177.51. Chipotle Mexican Grill (NYSE:CMG) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $70.00 price target on the stock. This represents a 18.9% upside from the current price of $58.87. Core Scientific (NASDAQ:CORZ) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $25.50 price target on the stock. This represents a 63.6% upside from the current price of $15.59. Doximity (NASDAQ:DOCS) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $58.00 price target on the stock. This represents a 16.7% upside from the current price of $49.70. Everus (NYSE:ECG) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $71.00 price target on the stock. This represents a 26.2% upside from the current price of $56.28. EMCOR Group (NYSE:EME) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $600.00 price target on the stock. This represents a 19.8% upside from the current price of $500.63. First Advantage (NYSE:FA) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $22.00 price target on the stock. This represents a 25.1% upside from the current price of $17.58. Comfort Systems USA (NYSE:FIX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $524.00 price target on the stock. This represents a 17.8% upside from the current price of $444.99. Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $110.00 price target on the stock. This represents a 23.1% upside from the current price of $89.36. Grail (NASDAQ:GRAL) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $14.74. HealthEquity (NASDAQ:HQY) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "neutral" rating and a $108.00 price target on the stock. This represents a 9.7% upside from the current price of $98.44. Johnson & Johnson (NYSE:JNJ) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $190.00 price target on the stock. This represents a 23.6% upside from the current price of $153.66. Eli Lilly and Company (NYSE:LLY) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $1,000.00 price target on the stock. This represents a 33.2% upside from the current price of $750.99. Limbach (NASDAQ:LMB) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $108.00 price target on the stock. This represents a 20.4% upside from the current price of $89.70. Merck & Co., Inc. (NYSE:MRK) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.The current price is $96.51. Moderna (NASDAQ:MRNA) is now covered by analysts at Wolfe Research. They set an "underperform" rating and a $40.00 price target on the stock. This represents a 11.3% upside from the current price of $35.93. Mersana Therapeutics (NASDAQ:MRSN) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $5.00 price target on the stock. This represents a 112.8% upside from the current price of $2.35. Insight Enterprises (NASDAQ:NSIT) is now covered by analysts at Redburn Atlantic. They set a "buy" rating and a $220.00 price target on the stock. This represents a 46.4% upside from the current price of $150.30. Pfizer (NYSE:PFE) is now covered by analysts at Wolfe Research. They set an "underperform" rating and a $25.00 price target on the stock. This represents a 0.6% upside from the current price of $24.86. Regeneron Pharmaceuticals (NASDAQ:REGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $1,150.00 price target on the stock. This represents a 51.0% upside from the current price of $761.50. Starbucks (NASDAQ:SBUX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $115.00 price target on the stock. This represents a 16.8% upside from the current price of $98.46. Simulations Plus (NASDAQ:SLP) is now covered by analysts at Stephens. They set an "overweight" rating and a $39.00 price target on the stock. This represents a 35.0% upside from the current price of $28.89. Teladoc Health (NYSE:TDOC) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $14.00 price target on the stock. This represents a 56.4% upside from the current price of $8.95. Veracyte (NASDAQ:VCYT) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $50.00 price target on the stock. This represents a 38.5% upside from the current price of $36.11. View More New Coverage Calendars from MarketBeat U.S. Analyst Ratings Corporate Buybacks Cryptocurrencies Dividend Declarations Earnings Announcements Earnings Conference Calls Economic Reports Gap Up/Down Stocks Insider Trades Initial Public Offerings (IPOs) Most Active Stocks Percentage Gainers/Decliners Sector Performance Short Interest Stock Splits Unusual Options Volume Unusual Trading Volume Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Upgrade Your Subscription Upgrade to MarketBeat All Access and receive your premium edition of MarketBeat Daily at 9:00 AM ET. Upgrade Now Manage Your Watchlist View and add up to five holdings to your watchlist. View My Portfolio Join Our Facebook Group Join MarketBeat's free stock discussion and trading idea group on Facebook. Join Now Thank you for subscribing to MarketBeat! We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: Trump won. Buy this coin now.